Vancomycin 500mg/100ml Inj, 100ml
Overview
What is this medicine?
How to Use This Medicine
If you need to store this medication at home, consult with your doctor, nurse, or pharmacist for guidance on proper storage procedures.
If you miss a dose, contact your doctor immediately to determine the best course of action.
Lifestyle & Tips
- Report any changes in hearing or ringing in the ears immediately.
- Report any signs of kidney problems, such as decreased urination or swelling.
- Inform healthcare providers about all medications, supplements, and herbal products being taken.
- Stay well-hydrated unless otherwise instructed by a doctor.
Available Forms & Alternatives
Available Strengths:
- Vancomycin 1000mg Inj
- Vancomycin 500mg Vial Forinjection
- Vancomycin 500mg Inj, 1 Vial
- Vancomycin 10gm Inj, 1 Vial
- Vancomycin 5gm Inj, 1 Vial
- Vancomycin 1000mg Inj (ad-Vantage)
- Vancomycin 5gm Inj, 1 Vial
- Vancomycin 750mg Inj, 1 Vial
- Vancomycin 1gm Inj, 1 Vial
- Vancomycin 125mg Capsules
- Vancomycin 250mg Capsules
- Vancomycin 1gm/200m Inj 12x200ml
- Vancomycin 250mg/5ml Oral Solution
- Vancomycin 10gm Inj, 1 Vial
- Vancomycin 1.25gm Inj 1 Vial
- Vancomycin 25mg/ml Oral Soln 300ml
- Vancomycin 25mg/ml Oral Soln 150ml
- Vancomycin 25mg/ml Oral Soln 300ml
- Vancomycin 25mg/ml Oral Soln 150ml
- Vancomycin 50mg/ml Oral Solution
- Vancomycin 1.5mg Inj, 1 Vial
- Vancomycin 1.75gm/350ml Inj, 350ml
- Vancomycin 750mg/150ml Inj, 150ml
- Vancomycin 1.5gm/300ml Inj, 300ml
- Vancomycin 500mg/100ml Inj, 100ml
- Vancomycin 125mg Capsules
- Vancomycin 250mg Capsules
- Vancomycin Hcl 1.75gm Inj, 1 Vial
- Vancomycin Hcl 2gm Sdv Inj, 1 Vial
Dosing & Administration
Adult Dosing
Condition-Specific Dosing:
Pediatric Dosing
Dose Adjustments
Renal Impairment:
Hepatic Impairment:
Pharmacology
Mechanism of Action
Pharmacokinetics
Absorption:
Distribution:
Elimination:
Pharmacodynamics
Safety & Warnings
Side Effects
Although rare, this medication can cause severe and potentially life-threatening side effects. If you experience any of the following symptoms, contact your doctor or seek medical attention immediately:
Signs of an allergic reaction, such as:
+ Rash
+ Hives
+ Itching
+ Red, swollen, blistered, or peeling skin with or without fever
+ Wheezing
+ Tightness in the chest or throat
+ Trouble breathing, swallowing, or talking
+ Unusual hoarseness
+ Swelling of the mouth, face, lips, tongue, or throat
Signs of kidney problems, including:
+ Inability to pass urine
+ Changes in urine output
+ Blood in the urine
+ Sudden weight gain
Severe skin reactions, such as:
+ Stevens-Johnson syndrome (SJS)
+ Toxic epidermal necrolysis (TEN)
+ Other serious reactions that can affect body organs and be life-threatening
+ Symptoms may include:
- Red, swollen, blistered, or peeling skin
- Red or irritated eyes
- Sores in the mouth, throat, nose, eyes, genitals, or skin
- Fever
- Chills
- Body aches
- Shortness of breath
- Swollen glands
If you receive this medication through a vein (intravenous injection):
+ Fever
+ Chills
+ Sore throat
+ Pain when passing urine
+ Changes in balance
+ Flushing
+ Rash on the face, neck, trunk, and arms during infusion
If the medication is given too quickly, you may experience:
+ Shortness of breath or wheezing
+ Itching
+ Muscle pain
+ Chest pain
+ Signs of low blood pressure, such as dizziness or fainting
If the medication leaks from the vein, it can cause tissue damage. Inform your nurse immediately if you experience:
+ Redness
+ Burning
+ Pain
+ Swelling
+ Blisters
+ Skin sores
+ Leaking of fluid at the injection site
Other Possible Side Effects
Like all medications, this drug can cause side effects. Many people may not experience any side effects or only minor ones. However, if you are bothered by any of the following side effects or if they persist, contact your doctor:
Diarrhea
Stomach pain
Upset stomach
Vomiting
This is not an exhaustive list of possible side effects. If you have questions or concerns about side effects, consult your doctor. You can also report side effects to the FDA at 1-800-332-1088 or online at https://www.fda.gov/medwatch.
Seek Immediate Medical Attention If You Experience:
- Redness, itching, or rash on the face, neck, or upper body (Red Man Syndrome) during or shortly after infusion.
- Dizziness, ringing in the ears (tinnitus), or hearing loss.
- Decreased urine output, swelling in legs or feet.
- Fever, chills, sore throat, or unusual tiredness (signs of low white blood cell count).
- Unusual bleeding or bruising.
- Severe diarrhea (could indicate C. difficile infection, though less common with IV vancomycin).
Before Using This Medicine
It is essential to inform your doctor about the following:
Any allergies you have, including allergies to this medication, its components, or other substances, such as foods or drugs. Be sure to describe the symptoms you experienced as a result of the allergy.
All medications you are currently taking, including prescription and over-the-counter (OTC) drugs, natural products, and vitamins. This information will help your doctor and pharmacist assess potential interactions between this medication and other substances you are taking.
* Any health problems you have, as this medication may interact with certain conditions.
To ensure your safety, it is crucial to verify that it is safe to take this medication with all your other medications and health conditions. Do not initiate, discontinue, or modify the dose of any medication without first consulting your doctor.
Precautions & Cautions
If you have a history of kidney problems, such as kidney failure, notify your doctor, as this medication can cause kidney issues. Your doctor will likely recommend regular blood tests and other laboratory evaluations to monitor your condition.
Long-term use of this medication may increase the risk of permanent hearing loss. Do not exceed the prescribed duration of treatment, and immediately report any changes in your hearing or hearing loss to your doctor. Your doctor may recommend regular hearing tests during treatment.
To minimize the risk of a secondary infection, do not use this medication for longer than prescribed.
As with many antibiotics, diarrhea is a common side effect. However, in rare cases, a severe form of diarrhea called Clostridioides difficile-associated diarrhea (CDAD) can occur, potentially leading to life-threatening bowel problems. CDAD may develop during or after treatment, sometimes several months later. If you experience stomach pain, cramps, or loose, watery, or bloody stools, contact your doctor promptly. Before treating diarrhea, consult with your doctor.
This medication is not approved for injection into the eye, as it can cause severe eye problems, including permanent vision loss.
If you are 65 years or older, use this medication with caution, as you may be more susceptible to side effects.
If you are pregnant, plan to become pregnant, or are breastfeeding, discuss the potential benefits and risks with your doctor. For women of childbearing age, your doctor may require a pregnancy test before initiating treatment to confirm that you are not pregnant.
Overdose Information
Overdose Symptoms:
- Severe kidney damage (renal failure)
- Hearing loss (ototoxicity)
- Hypotension
- Red Man Syndrome
What to Do:
Seek immediate medical attention. Call 911 or Poison Control at 1-800-222-1222. Treatment is supportive, including maintaining hydration, monitoring renal function, and potentially hemodialysis to remove vancomycin from the blood in severe cases.
Drug Interactions
Major Interactions
- Aminoglycosides (e.g., gentamicin, tobramycin, amikacin): Increased risk of nephrotoxicity and ototoxicity.
- Loop diuretics (e.g., furosemide): Increased risk of ototoxicity.
- Cisplatin: Increased risk of nephrotoxicity and ototoxicity.
- Cyclosporine: Increased risk of nephrotoxicity.
- Tacrolimus: Increased risk of nephrotoxicity.
- Polymyxin B: Increased risk of nephrotoxicity.
- Amphotericin B: Increased risk of nephrotoxicity.
Moderate Interactions
- Neuromuscular blockers (e.g., succinylcholine, rocuronium): May potentiate or prolong neuromuscular blockade.
- Metformin: Vancomycin may increase metformin levels (though less common with IV vancomycin).
- Radiographic contrast agents: Increased risk of nephrotoxicity, especially in patients with pre-existing renal impairment.
Monitoring
Baseline Monitoring
Rationale: Vancomycin is primarily renally eliminated; renal impairment necessitates dose adjustment and increases risk of toxicity.
Timing: Prior to initiation of therapy.
Rationale: To establish baseline and monitor for potential neutropenia or thrombocytopenia.
Timing: Prior to initiation of therapy.
Rationale: To establish baseline for potential ototoxicity.
Timing: Prior to initiation of therapy.
Routine Monitoring
Frequency: Prior to the 4th or 5th dose (at steady state), then at least weekly or more frequently if renal function changes or dose adjustments are made.
Target: 10-15 mcg/mL for most infections; 15-20 mcg/mL for serious infections (e.g., endocarditis, osteomyelitis, meningitis, HAP/VAP, bacteremia).
Action Threshold: Levels outside target range; adjust dose to achieve target.
Frequency: At least 2-3 times per week, or daily in critically ill patients or those with unstable renal function.
Target: Stable or improving renal function.
Action Threshold: Increase in SCr by âĨ0.5 mg/dL or âĨ50% from baseline; consider dose adjustment or alternative therapy.
Frequency: Weekly, especially with prolonged therapy.
Target: Normal ranges for WBC, platelets.
Action Threshold: Significant decrease in WBC (especially neutrophils) or platelets; consider discontinuation or alternative therapy.
Frequency: Daily patient assessment; formal audiology if symptoms develop.
Target: No new hearing loss, tinnitus, or vertigo.
Action Threshold: New onset of hearing loss, tinnitus, or vertigo; consider discontinuation or alternative therapy.
Symptom Monitoring
- Red man syndrome (flushing, rash, pruritus, urticaria, tachycardia, hypotension) during infusion
- Hearing loss, tinnitus, vertigo
- Signs of kidney injury (decreased urine output, swelling)
- Fever, chills, sore throat (signs of neutropenia)
- Unusual bleeding or bruising (signs of thrombocytopenia)
- Injection site reactions (pain, phlebitis)
Special Patient Groups
Pregnancy
Category C. Use during pregnancy only if clearly needed and potential benefits outweigh potential risks to the fetus. Vancomycin crosses the placenta.
Trimester-Specific Risks:
Lactation
L3 (Moderately Safe). Vancomycin is excreted into breast milk in small amounts. Monitor breastfed infant for changes in bowel habits (diarrhea), thrush, or rash. Risk of affecting infant gut flora or sensitization is theoretical.
Pediatric Use
Dosing is weight-based and requires careful therapeutic drug monitoring (TDM) due to variable pharmacokinetics in different age groups, especially neonates and infants. Renal function must be closely monitored.
Geriatric Use
Increased risk of renal impairment, which necessitates careful dose adjustment and close monitoring of renal function and vancomycin trough levels. Elderly patients may also be more susceptible to ototoxicity.
Clinical Information
Clinical Pearls
- Always administer vancomycin IV infusions slowly over at least 60 minutes (or longer for doses >1g) to minimize the risk of Red Man Syndrome.
- Therapeutic drug monitoring (TDM) with trough levels is crucial for optimizing efficacy and minimizing toxicity, especially for serious infections or in patients with unstable renal function.
- Target trough levels vary based on the severity and type of infection (10-15 mcg/mL for less severe, 15-20 mcg/mL for severe infections).
- Hydration is important to reduce the risk of nephrotoxicity.
- Avoid concomitant use with other nephrotoxic or ototoxic drugs whenever possible, or monitor patients extremely closely if co-administration is necessary.
- Vancomycin is not effective against Gram-negative bacteria.
Alternative Therapies
- Linezolid (for MRSA, VRE)
- Daptomycin (for MRSA, VRE)
- Ceftaroline (for MRSA)
- Tedizolid (for MRSA)
- Dalbavancin (for MRSA)
- Oritavancin (for MRSA)
- Tigecycline (for MRSA, VRE)